enVVeno Medical Corp (NVNO)
3.41
+0.01
(+0.29%)
USD |
NASDAQ |
Nov 14, 16:00
3.40
-0.01
(-0.29%)
After-Hours: 20:00
enVVeno Medical Research and Development Expense (Quarterly): 2.859M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.859M |
| June 30, 2024 | 2.825M |
| March 31, 2024 | 3.052M |
| December 31, 2023 | 2.981M |
| September 30, 2023 | 2.798M |
| June 30, 2023 | 4.214M |
| March 31, 2023 | 3.595M |
| December 31, 2022 | 2.797M |
| September 30, 2022 | 2.492M |
| June 30, 2022 | 3.073M |
| March 31, 2022 | 1.552M |
| December 31, 2021 | 1.782M |
| September 30, 2021 | 1.225M |
| June 30, 2021 | 1.09M |
| March 31, 2021 | 1.632M |
| December 31, 2020 | 2.277M |
| September 30, 2020 | 0.7582M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.7062M |
| March 31, 2020 | 0.5106M |
| December 31, 2019 | 0.7878M |
| September 30, 2019 | 0.677M |
| June 30, 2019 | 0.4283M |
| March 31, 2019 | 0.313M |
| December 31, 2018 | 0.2932M |
| September 30, 2018 | 0.4246M |
| June 30, 2018 | 0.2804M |
| March 31, 2018 | 0.2405M |
| December 31, 2017 | 0.3491M |
| September 30, 2017 | 0.0431M |
| June 30, 2017 | 0.1849M |
| March 31, 2017 | 0.0727M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.5106M
Minimum
Mar 2020
4.214M
Maximum
Jun 2023
2.150M
Average
2.385M
Median
Research and Development Expense (Quarterly) Benchmarks
| NeuroOne Medical Technologies Corp | 1.195M |
| SINTX Technologies Inc | 1.677M |
| Nutriband Inc | 0.774M |
| Beyond Air Inc | 6.009M |
| CVRx Inc | 2.504M |